| |

CT Evaluation Correlates with Actual Mesothelioma Tumor Volume, Subtype, and Survival

ByAlex Strauss

CT evaluationTwo new studies highlight the value of CT evaluation for patients with either peritoneal or pleural mesothelioma. 

CT stands for computed tomography. The technology uses X-rays to create three dimensional images of internal structures. 

The studies show CT evaluation can give doctors an accurate idea of the size and extent of mesothelioma tumors. These scans can also help predict which patients have the best odds of survival. This helps doctors plan better, more effective treatment strategies. 

What is Malignant Mesothelioma?

Malignant mesothelioma is a type of cancer that grows on the membranes around internal organs. The most common type of mesothelioma is pleural mesothelioma. This kind of tumor starts on the pleural membrane around the lungs. 

Peritoneal mesothelioma accounts for about a fifth of mesothelioma cases. Peritoneal mesothelioma tumors grow on the peritoneum. This membrane surrounds the abdominal organs.

It is common for patients with mesothelioma to undergo CT evaluation. But how well do these images depict what is really going on inside? And how does that relate to mesothelioma survival? These are the questions researchers in Switzerland and the US wanted to answer. 

CT Evaluation and Real World Mesothelioma Outcomes

Doctors classify mesothelioma into three subtypes. Some subtypes are more aggressive than others. A patient’s subtype impacts what kind of treatments will work best. Right now, the only way to determine mesothelioma subtype is to look at tumor cells under a microscope.

But researchers at Boston’s Massachusetts General Hospital wanted to know how much CT evaluation could help. They compared the subtypes of 51 peritoneal mesothelioma patients with their CT images.

Eighty percent of patients had epithelioid mesothelioma. The other 20 percent had a sarcomatoid subtype (either pure sarcomatoid or biphasic, which is a mix of epithelioid and sarcomatoid cells). How aggressive the cancer was on CT evaluation correlated closely with subtype. 

“Sarcomatoid type of MPM showed significant correlation with more aggressive imaging features of metastases and visceral [deep in the membrane] infiltration as compared to epithelioid type,” writes study author Isha Atre. 

Higher CT Tumor Volume = Shorter Mesothelioma Survival

The second study compared CT measurements of the volume and thickness of pleural mesothelioma tumors with their actual measurements after surgery. The goal of the Swiss researchers was to see a) how accurate the measurements were and b) how they related to mesothelioma survival.

“Preoperatively assessed CT tumor volume and actual tumor volume showed a significant correlation,” writes author Olivia Lauk of University Hospital Zurich.

The team also determined that CT evaluation of tumor volume correlated with overall survival. CT measurements of tumor thickness did not. 

“CT tumor volume may predict pathological tumor volume as a reflection of tumor burden, which supports the integration of CT tumor volume into future staging systems,” Lauk concludes. 

Source:

Atre, I, et al, “Malignant peritoneal mesothelioma: correlation between CT imaging features and histologic subtypes”, August 3, 2021, Abdominal Radiology, Online ahead of print, https://link.springer.com/article/10.1007%2Fs00261-021-03231-4

Lauk, O, et al, “Implementing CT tumor volume and CT pleural thickness into future staging systems for malignant pleural mesothelioma”, August 3, 2021, Cancer Imaging, https://cancerimagingjournal.biomedcentral.com/articles/10.1186/s40644-021-00415-5

Similar Posts

  • |

    Mesothelioma Blood Test May Be Possible

    ByAlex Strauss

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    ByAlex Strauss

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…

  • | |

    Inflammation Both “Friend and Foe” in Mesothelioma

    ByAlex Strauss

    An immune system response that causes mesothelioma symptoms such as fever, fatigue, and weight loss may also be helpful to clinicians as a way to find and treat the disease. Scientists with The Asbestos Diseases Research Institute in Sydney, Australia make that case that both systemic inflammation (throughout the body) and at the site of a tumor – has long been associated with mesothelioma and other cancers. Inflammation results when the body attempts to address the imbalances of cancer by producing more of certain immune system cells. Some inflammatory markers, such as CD+8 T-cells and C-reactive protein, have been linked to better prognosis in mesothelioma. Other inflammatory markers, such as certain macrophages and a high neutrophil-to-lymphocyte ratio, can signal the…

  • |

    New Prognostic Factor in Peritoneal Mesothelioma

    ByAlex Strauss

    Malignant peritoneal mesothelioma is a rare form of mesothelioma that attacks the membrane that lines the abdomen and surrounds internal organs. The outlook for this rare malignancy, which affects fewer than 500 Americans annually, has been improved by the treatment combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). The combination has produced 5-year overall survival rates ranging from 29% to 63%. But not all peritoneal mesothelioma patients are good candidates for CRS/HIPEC. The challenge, for clinicians, is identifying which patients are likely to benefit from the procedure (or even be cured) and which are not. In an effort to help answer that question, French researchers recently tested the prognostic value of the glucose transporter protein GLUT1 as well as…

  • | |

    FDG PET-CT Results Could Lead to Improved Mesothelioma Treatment

    ByAlex Strauss

    In a recent study, researchers say a better understanding of certain diagnostic criteria could result in more targeted treatments for malignant mesothelioma. In a recent published report, doctors from the medical school at Dicle University in Diyarbakir, Turkey measured the relationship between PET-CT scan results and survival in 177 patients with malignant pleural mesothelioma. The patients were diagnosed between April 2007 and April 2011. They had a mean age of 55.4 and most (56%) were male. Patients in the study all had FDG PET-CT scans before beginning their mesothelioma treatment. FDG PET-CT scanning is a powerful imaging tool for mesothelioma and other cancers that combines a radioactive tracer with a combination of positron emission tomography and computed tomography scanning.  Because…

  • | |

    Mesothelioma Surgeons Report New Biopsy Technique

    ByAlex Strauss

    A team of surgeons in Maryland have demonstrated how using a standard biopsy tool in a new way could improve the biopsy process for certain mesothelioma patients. An aggressive cancer of the pleural lining around the lungs, malignant pleural mesothelioma usually requires a tissue biopsy to make a definitive diagnosis. Often this is done using a rigid tool called a thoracoscope inserted into the chest wall while the patient is under general anesthesia. However, mesothelioma doctors at Walter Reed National Military Medical Center detail the case of a 79-year-old suspected mesothelioma patient whose biopsy was done in a minimally-invasive way, under conscious sedation, thanks to the novel use of a standard tool. Although the patient had several of the common signs…